Skip to content

National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics

Investigating ELSI Issues That May Facilitate or Impede Clinical Translation of Epigenetic Research: National Survey

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07020234
Enrollment
2040
Registered
2025-06-13
Start date
2025-06-12
Completion date
2025-07-18
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Epigenomics, Epigenetics, Genetics, Behavioral, Bioethics

Brief summary

Few people realize that environmental pollution and some behaviors like physical activity and tobacco smoking can affect their health by turning on or turning off certain genes through a process called epigenetic modification. This study will develop and test strategies for communicating about epigenetics that are understandable and that increase acceptance of using epigenetics in clinical settings.

Interventions

Educational video about health and epigenetics.

BEHAVIORALNanotechnology Video

Educational video about nanotechnology

Sponsors

National Institute of Environmental Health Sciences (NIEHS)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

English language speaker, Identify as one of five racial/ethnic groups: 1. Non-Hispanic White 2. Non-Hispanic Black, 3. Non-Hispanic Asian 4. Non-Hispanic Indigenous (i.e., Alaska Native/Native Hawaiians/American Indian/Other Pacific Islander) 5. Hispanic (all races)

Exclusion criteria

* Self-identify as a genetics expert

Design outcomes

Primary

MeasureTime frameDescription
Knowledge & understanding of epigenetics InformationAt enrollmentWe will measure this outcome using a sum score of correct answers for 8 individual items.

Secondary

MeasureTime frameDescription
Perceptions of epigenetic informationAt enrollmentWe will measure this outcome using an 8 item scale.
Acceptability of epigenetics informationAt enrollmentWe will measure this outcome using 3 different constructs including perceived benefits of epigenetic research (7 item scale), perceived drawbacks of epigenetic research (3 items), and acceptance of using epigenetic research in medical support (3 items).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026